Another great post by JFM. Figure I'd post it bef
Post# of 72440
(Total Views: 820)
Posted On: 07/02/2021 5:54:25 PM
Another great post by JFM. Figure I'd post it before they take it down. He literally destroyed paid poster RDUNN
Rdunn... commentary is full of false belief and no experience in the process of one company transferring to an acquiring company the "IP" i.e. Intellectual Property ("IP" not referring to IPXI) from another...
As pointed out by many posters...the sale and transfer of the Brilacidin IP as well as licensing...has absolutely nothing to do with the number of employees or medical/scientific experience of those with authority to transfer.
An Acquiror of all the IP (total acquisition of the asset, i.e. IP) or Licensee (an acquiring of a specific and limited right in time or scope to use that IP)... do their DD on the science...and regulatory filings to assure themselves and their shareholders that they are acquiring the asset they intend.
With IPIX...THEY ARE NOT GOING TO ACQUIRE THE COMPANY with its EMPLOYEES... This will be an intellectual property sale or license agreement(s).
If you are advocating or suggesting "Partnership"...you are not even close. "Partnership" is not the fate of IPIX...sale or licensing of IP is. You went down the wrong "Wabbit-hole"!
A Corporate Board of a company acquiring could give a "rats ass" about who is putting his or her signature to the document transferring the IP. As long as the corp. the officer has the authority (like Board and in some cases the Shareholders) ... that, after confirming via its DD, is the only function of the Corp. Officer.
Of course, Leo's press releases are not germane to DD. Acquiror NEVER make their decision on acquiring in whole or licensing upon what the company or its officers have represented...they depend and solely rely upon their OWN team to confirm what has been represented not only by officers of the selling company, but regulators and scientific data received. In fact, specific language in the Asset Purchase agreement will reference that the "Acquiror/Purchaser has NOT RELIED UPON THE TRANSFEROR'S Representations and represents that the Acquiror has relied solely upon its own DD".
ITS ALL ABOUT PROVING OUT THE SCIENCE...(thank you Dr. DeGrado!)
Rdunn... commentary is full of false belief and no experience in the process of one company transferring to an acquiring company the "IP" i.e. Intellectual Property ("IP" not referring to IPXI) from another...
As pointed out by many posters...the sale and transfer of the Brilacidin IP as well as licensing...has absolutely nothing to do with the number of employees or medical/scientific experience of those with authority to transfer.
An Acquiror of all the IP (total acquisition of the asset, i.e. IP) or Licensee (an acquiring of a specific and limited right in time or scope to use that IP)... do their DD on the science...and regulatory filings to assure themselves and their shareholders that they are acquiring the asset they intend.
With IPIX...THEY ARE NOT GOING TO ACQUIRE THE COMPANY with its EMPLOYEES... This will be an intellectual property sale or license agreement(s).
If you are advocating or suggesting "Partnership"...you are not even close. "Partnership" is not the fate of IPIX...sale or licensing of IP is. You went down the wrong "Wabbit-hole"!
A Corporate Board of a company acquiring could give a "rats ass" about who is putting his or her signature to the document transferring the IP. As long as the corp. the officer has the authority (like Board and in some cases the Shareholders) ... that, after confirming via its DD, is the only function of the Corp. Officer.
Of course, Leo's press releases are not germane to DD. Acquiror NEVER make their decision on acquiring in whole or licensing upon what the company or its officers have represented...they depend and solely rely upon their OWN team to confirm what has been represented not only by officers of the selling company, but regulators and scientific data received. In fact, specific language in the Asset Purchase agreement will reference that the "Acquiror/Purchaser has NOT RELIED UPON THE TRANSFEROR'S Representations and represents that the Acquiror has relied solely upon its own DD".
ITS ALL ABOUT PROVING OUT THE SCIENCE...(thank you Dr. DeGrado!)
(9)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼